Skip to main content
Log in

The rising threat of Mpox in Japan despite global decrease

Journal of Public Health Policy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions


  1. Ministry of Health, Labor and Welfare. About Monkeypox [in Japanese]. 2023 Available from: Accessed 18 April 2023.

  2. O’Laughlin K, et al. Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol—United States, May-August 2022. MMWR Morb Mortal Wkly Rep. 2022;71(37):1190–5.

    Article  Google Scholar 

  3. McQuiston, J.H., The CDC domestic Mpox response—United States, 2022–2023. MMWR. Morbidity and Mortality Weekly Report, 2023;72:80.

    Article  Google Scholar 

  4. Thornhill JP, et al. Monkeypox virus infection in humans across 16 countries—April-June 2022. N Engl J Med. 2022;387(8):679–91.

    Article  Google Scholar 

  5. Wang Y, et al. Elimination of HIV transmission in Japanese MSM with combination interventions. Lancet Reg Health West Pac. 2022;23: 100467.

    Article  Google Scholar 

  6. Yu F, et al. The influence of anticipated HIV stigma on health-related behaviors, self-rated health, and treatment preferences among people living with HIV in East Asia. AIDS Behav. 2023;27(4):1287–303.

    Article  Google Scholar 

  7. Traore T, et al. How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach. The Lancet. 2023;401(10377):673–87.

    Article  Google Scholar 

  8. Brown HL, et al. The One Health European Joint Programme (OHEJP), 2018–2022: an exemplary One Health initiative. J Med Microbiol. 2020;69(8):1037–9.

    Article  Google Scholar 

Download references





Author information

Authors and Affiliations



Conception and designing of the study; YK. Data collection and Interpretation; YK and KI. Writing this paper; YK. Critical revision of the paper; RS and KT. Supervision; KT. All the authors read the final draft and approved submission.

Corresponding author

Correspondence to Yudai Kaneda.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaneda, Y., Shrestha, R., Iwahashi, K. et al. The rising threat of Mpox in Japan despite global decrease. J Public Health Pol 44, 499–502 (2023).

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: